 and can be reached at mrivers@mjhlifesciences.com.

The 2023 Emerging Pharma Leaders share with the Pharmaceutical Executive editors what makes a good leader, what has made them the proudest in their career, lessons they wish they had known when starting out, and more.

Our 2023 Emerging Pharma Leaders

Torrey Cope, partner, food, drug, and medical device practice, Sidley Austin LLP, reveals current regulatory challenges in the U.S. for drug approvals, how a one-sized-fits-all approach to marketing and global launches no longer works, and when a global launch may be advantageous.  

Drug Approvals and Launches from a Legal Perspective

 and can be reached at fpollaro@mjhlifesciences.com.

Join host Fran Pollaro as he delves into the world of patient-centric dermatology innovations with Arcutis president and CEO Frank Watanabe in this Pharmaceutical Executive Podcast episode.

Exploring Arcutis’s Patient-Centric Dermatology Innovations

Elizabeth (Beth) Garner, chief scientific officer for Ferring Pharmaceuticals, discusses her transition from being a physician to working in pharma, new technologies in reproductive health for men and women, as well as access limitations in fertility treatment. 

Tackling Reproductive Health and Fertility Care 

Increasingly clinical pharma and biotech organizations are deciding to commercialize on their own; just as Contract Research Organizations (CROs) transformed clinical trial operations, Contract Commercial Services are transforming commercial operations. Emerging service models offer new options for clinical organizations. In this podcast, Brent Herspiegel, CEO, and Santosh Naik, Partner, Herspiegel Consulting, share the considerations for pharma and biotech organizations when deciding on their commercial path and partner. How Contract Commercial Services can mitigate common launch risks, what we can learn from Herspiegel Consulting’s experience with 100+ pharma product launches.

Contract Commercial Services Redefining How Biotechs Bring Products to Market

Two companies team up to combat rare diseases through drug repurposing,
which was heavily informed by one doctor’s experience through unconventionally treating his Castleman disease and (ultimately) saving his own life.

Repurposing Drugs: How One Doctor Saved His Own Life and Hopes to Save Others

Fran Pollaro talks with Cathi Ahearn, senior vice president, worldwide commercial portfolio strategy, Bristol Myers Squibb about impediments and solutions to break down silos in order to get medications in the hands of patients faster.

Tearing Down Silos to Usher Innovative Medicines to Patients Faster

Rebekah Martin, senior VP of reward, inclusion, and talent acquisition at AstraZeneca, discusses recruiting talent in pharma, including finding and keeping the right talent, identifying and nurturing talent (students, specifically), and diversity in the workforce.

Recruiting Talent In Pharma

Join Tina Fascetti, CCO of The Agency Network at MJH Life Sciences for a podcast interview with Ryan Potter, ACD Art, and Priscila Ramos, ACD Copy, from McCann Health as they share the "behind the creative" story of their Apex Award-winning consumer creative campaign for Entresto. The Apex Awards is judged by none other than the people they are aimed to connect with, the patients themselves.

Behind the Creative: Let’s Hear from the Creators

Fran Pollaro talks with Faruk Capan is the CEO, EVERSANA INTOUCH & Chief Innovation Officer, EVERSANA about the arrival of Chat GPT and generative AI in the public consciousness. This is just the beginning.

Podcasts